Patent Application
20240009377
The present disclosure relates generally to a wound therapy system, and more particularly to a wound therapy system that provides negative pressure wound therapy (NPWT). NPWT refers to the creation of negative pressure (relative to atmospheric pressure) at a wound to promote healing of the wound. In a wound therapy system configured to provide NPWT, a dressing is typically sealed over a wound bed and placed in fluid communication with a pump operable to draw a negative pressure at the wound bed (i.e., in a wound space between the wound bed and the dressing). Because the dressing is sealed over the wound bed, often for a period of multiple days, it would be advantageous to determine wound volume without having to remove the dressing. In some cases, NPWT may be provided in coordination with instillation therapy and described as negative pressure and instillation wound therapy (NPIWT). Instillation therapy refers to the provision of instillation fluid (e.g., saline, antibiotic fluid, etc.) to the wound. One challenge in instillation therapy may be determining how much fluid to provide to the wound. It may be preferable to determine an amount of fluid to provide based on a size of the wound and/or a volume of available space adjacent the wound (i.e., between the dressing and the wound). Determining wound volume and instillation volume may involve use of sensors that measure an amount of air being withdrawn by the pump. Maintaining the flow of air in a laminar state for detection by the sensors may help improve the accuracy of the volume determination. Accordingly, systems and methods for maintaining a laminar flow of air for volume determination in a wound therapy system may be advantageous.
One implementation of the present disclosure is a wound therapy system. The wound therapy system includes a dressing sealable over a wound and defining a wound space between the dressing and the wound, tubing comprising a first inner diameter, wherein the tubing is coupled to the dressing and fluidly communicable with the wound space, and a canister fluidly communicable with the tubing. The canister, the tubing, and the dressing define a sealed space comprising the wound space. A therapy unit is coupled to the canister and includes a pneumatic pump fluidly communicable with the sealed space, a sensor configured to measure a pressure in the sealed space, a valve positioned between the sealed space and surrounding environment and controllable between an open position and a closed position, and a control circuit. The control circuit is configured to control the pneumatic pump to remove air from the sealed space to establish a negative pressure in the sealed space, control the valve to repeatedly alternate between the open position and the closed position to allow a controlled rate of airflow through the valve, receive measurements of the pressure in the sealed space from the sensor, and determine a volume of the wound space based on the measurements of the pressure. A portion of the tubing comprises a second inner diameter that is less than the first inner diameter.
In some embodiments, the second inner diameter ranges between a first value of approximately 0.33 mm and a second value of approximately 0.43 mm.
In some embodiments, a location of the second inner diameter is between the dressing and the canister. The location of the second inner diameter can be at an interface of the canister and the tubing.
In some embodiments, a location of the second inner diameter is between the dressing and the therapy unit. The location of the second inner diameter can be at an interface of the therapy unit and the tubing.
In some embodiments, the portion of the tubing comprising the second inner diameter is structured as a disc having an aperture formed therein and disposed within a lumen of the tubing.
Another implementation of the present disclosure is an apparatus. The apparatus includes a plate having a first end coupled to a canister and a second end coupled to tubing. The plate defines a lumen having a first diameter extending between the first end and the second end. The apparatus also includes an insert having an orifice extending therethrough. The orifice defines a second diameter. The insert can be disposed at the first end of the plate such that the orifice substantially aligns with the lumen of the bellow. The apparatus also includes an overmold disposed over the insert and at least partially over a length of the plate defined between the first end and the second end. The overmold substantially secures the insert relative the bellows. The second diameter of the orifice is less than the first diameter of the lumen.
In some embodiments, the second diameter ranges between a first value of approximately 0.33 mm and a second value of approximately 0.43 mm.
In some embodiments, the insert is structured as a disc.
In some embodiments, the insert comprises a first insert end and a second insert end. An insert length measured between the first insert end and the second insert end is approximately 1.5 cm.
Another implementation of the present disclosure is a wound therapy system. The wound therapy system includes a dressing sealable over a wound and defining a wound space between the dressing and the wound, tubing comprising a first inner diameter, coupled to the dressing, and fluidly communicable with the wound space, and a canister defining a hollow volume therein and fluidly communicable with the tubing. The canister, the tubing, and the dressing define a sealed space comprising the wound space. The canister includes a canister interface configured to fluidly couple the tubing with the canister. The canister interface comprises an orifice having an interface diameter and extending from an exterior towards the hollow volume. The interface diameter is less than the first inner diameter. The wound therapy system also includes a therapy unit coupled to the canister. The therapy unit includes a pneumatic pump fluidly communicable with the sealed space, a sensor configured to measure a pressure in the sealed space, a valve positioned between the sealed space and surround environment and controllable between an open position and a closed position, and a control circuit. The control circuit is configured to control the pneumatic pump to remove air from the sealed space to establish a negative pressure in the sealed space, control the valve to repeatedly alternate between the open position and the closed position to allow a controlled rate of airflow through the valve, receive measurements of the pressure in the sealed space from the sensor, and determine a volume of the wound space based on the measurements of the pressure.
In some embodiments, the interface diameter ranges between a first value of approximately 0.33 mm and a second value of approximately 0.43 mm.
In some embodiments, the wound therapy system comprises an insert configured for placement within the interface lumen. The insert defines an orifice extending therethrough having an orifice diameter that is less than the first inner diameter. The orifice diameter can range between a first value of approximately 0.33 and a second value of approximately 0.43 mm.
Yet another implementation of the present disclosure is a method of treating a wound. The method comprises establishing a sealed space defined by a dressing, tubing having a first diameter, and a canister of a wound therapy system and comprising a wound space defined by the dressing and the wound, providing an orifice within the sealed space having a second diameter that is less than the first diameter, removing, with a pneumatic pump, air from the sealed space to establish a negative pressure in the sealed space, causing a valve to alternate between an open position and a closed position, measuring the negative pressure in the sealed space to generate pressure measurements, determining, based on the pressure measurements, a volume of the wound space, customizing a customized wound therapy based on the volume of the wound space, and providing the customized wound therapy to the wound.
In some embodiments, the second diameter ranging between a first value of approximately 0.33 mm and a second value of approximately 0.43 mm.
In some embodiments, the method involves providing the orifice via a disc defining the orifice extending therethrough.
In some embodiments, the method involves placing the disc within a lumen defined by the tubing.
In some embodiments, the method involves placing the disc within the lumen at a location between the dressing and the canister. The disc can be placed at a location of an interface of the canister and the tubing.
In some embodiments, the method involves placing the disc within the lumen at a location between the dressing and a therapy unit. The disc can be placed at a location of an interface of the therapy unit and the tubing.
In some embodiments, the method involves replacing the canister having the disc with another canister having another disc.
Yet another implementation of the present disclosure is a wound therapy system. The wound therapy system includes a dressing configured for placement over a wound, a therapy unit having a pneumatic pump operably coupled to a removable canister, tubing coupled to the dressing and the canister and defining a flowpath therethrough, and an orifice disposed within the flowpath and operable to maintain a flow through the flowpath in a laminar flow state.
In some embodiments, the orifice is disposed in a disc.
In some embodiments, the orifice is at a location on the canister at an interface of the canister and the tubing.
In some embodiments, the orifice defines an orifice diameter that ranges between a first value of 0.33 mm and 0.43 mm.
Various objects, aspects, features, and advantages of the disclosure will become more apparent and better understood by referring to the detailed description taken in conjunction with the accompanying drawings, in which like reference characters identify corresponding elements throughout. In the drawings, like reference numbers generally indicate identical, functionally similar, and/or structurally similar elements.
Referring generally to the FIGURES, a wound therapy system is shown according to various exemplary embodiments. The wound therapy system may include a therapy device and a wound dressing. The therapy device may include an instillation fluid canister, a removable fluid canister, a valve, a pneumatic pump, an instillation pump, a tubeset module, and a controller. The wound dressing can be applied to a patient's skin surrounding a wound. The therapy device can be configured to deliver instillation fluid to the wound and provide negative pressure would therapy (NPWT) by maintaining the wound at negative pressure. Components of the wound therapy device, the wound dressing, and the wound site form a negative pressure circuit.
The controller can be configured to operate the pneumatic pump, the instillation pump, the tubeset module, and/or other controllable components of the therapy device. In some embodiments, the controller estimates the volume of the wound based on a comparison of observed dynamic pressure responses to negative pressure being applied to the entirety of the negative pressure circuit and negative pressure being applied to a selected portion of the negative pressure circuit. Based on the comparison of the observed dynamic responses, the controller may be configured to determine a quantity of instillation fluid to be delivered to the wound site.
The observed dynamic pressure responses can be measured using one or more sensors. The one or more sensors are configured to measure the pressure of fluid flowing past and engaging with each sensor. Accordingly, it is desirable to maintain a smooth (e.g., laminar, restricted) flow of fluid past the sensor to provide more accurate measurements as opposed to mixed, irregular flow (e.g., turbulent flow). Disclosed herein is an orifice defining a smaller diameter (relative to tubing that couples a location of a sensor with the wound dressing) that provides a restriction to the flow of fluid through the tubing and influencing smooth, laminar, and/or restricted flow.
Wound Therapy System with In-Line Orifice
Referring to
The dressing 102 is shown as applied to a wound bed 114. The dressing 102 includes a drape 116 sealed over the wound bed 114 and a manifold layer 118 positioned between the drape 116 and the wound bed 114. In various embodiments, the dressing 102 may include various layers and features. A connection pad (e.g., low pressure interface) 121 is coupled to the drape 116 and facilitates connection of the first tubing 106 to the dressing 102. The drape 116 may be made of a substantially air-impermeable material (e.g., a polyurethane-based material) and may include an adhesive border that allows the drape to be sealed to a patient's skin around the wound bed 114. The manifold layer 118 may create a manifolding effect that allows airflow therethrough and facilitates the distribution of negative pressure across the wound bed 114. A wound space 120 that includes the open volume (i.e., through which air may flow) in the manifold layer 118 and otherwise situated between the drape 116 and the wound bed 114 is thereby established.
As described in detail with reference to
First tubing 106 includes an inner lumen 400 extending between the canister 104 and the drape 116 and one or more outer lumens 402 extending between therapy unit 108 and drape 116. The inner lumen 400 provides for the flow of fluid from the wound space 120 into the canister 104. The one or more outer lumens 402 are fluidly communicable with a second sensor 124. Second sensor 124 may collect similar measurements as first sensor 123. In various embodiments, NPIWT system 100 may include both first sensor 123 and second sensor 124. The one or more outer lumens 402 are also fluidly communicable with a second valve 126 as described below. It should be understood that, while described as inner and outer in the examples herein, any geometrical arrangement of multiple lumens may be used in various embodiments.
As shown in
In some embodiments in which orifice 404a is located at an interface of therapy unit 108 and vacuum tubing 403, orifice 404a may be provided as a component formed monolithically within the interface of therapy unit 108. In other embodiments, orifice 404a may be provided as a discrete component that is configured to be installed, inserted, or otherwise disposed in the interface of therapy unit 108.
In embodiments in which orifice 404c is located at an interface of canister 104 and vacuum tubing 403, orifice 404c may be provided as a component formed monolithically within the interface of canister 104. In other embodiments, orifice 404c may be provided as a discrete component that is configured to be installed, inserted, or otherwise disposed in the interface of canister 104. As such, when canister 104 is removed (e.g., upon being filled with wound exudate), the orifice 404c is removed with the canister 104. Accordingly, replacing the original canister 104 with another canister 104 involves replacing the original orifice 404c with another orifice 404c (e.g., an orifice 404c formed monolithically with canister 104, an orifice 404c installed or disposed within the interface of canister 104).
The canister 104 is configured to collect wound exudate (e.g., fluid, other debris) removed from the wound space 120 via the first tubing 106. The canister 104 is fluidly communicable with the wound space 120 via the first tubing 106. The canister 104, the first tubing 106, and the dressing 102 thereby define a sealed space that includes the wound space 120. In some embodiments, canister 104 provides orifice 404 at an interface between vacuum tubing 403 and canister 104. Alternatively, as will be described with reference to
The therapy unit 108 is pneumatically coupled to the canister 104 via vacuum tubing 403 and includes a pneumatic pump 122 fluidly communicable with the sealed space, a first sensor 123 configured and positioned to measure pressure in the sealed space, a first valve 125 positioned between the pneumatic pump and the canister 104, a user interface 128, and an instillation pump 130 coupled to the second tubing 112. The therapy unit 108 also includes a control circuit 132 communicably and operably coupled (e.g., capable of exchanging electronic signals with) the pneumatic pump 122, the first sensor 123, the first valve 125, the second sensor 124, the second valve 126, the user interface 128, and the instillation pump 130. In some embodiments, therapy unit 108 provides orifice 404 at an interface between vacuum tubing 403 and therapy unit 108. Alternatively, as will be described with reference to
The pneumatic pump 122 is controllable by the control circuit 132 and operable to pump (e.g., draw, remove) air from the canister 104, the first tubing 106, and the wound space 120 (i.e., from the sealed space). The pneumatic pump 122 may thereby create a negative pressure in the sealed space relative to atmospheric pressure, for example between 25 mmHg and 175 mmHg. The pneumatic pump 122 may create a pressure differential that causes fluid and debris to be drawn out of the wound space 120, through the first tubing 106, and into the canister 104.
The first sensor 123 and the second sensor 124 are positioned and configured to measure the pressure in the sealed space. As shown in
The user interface 128 may include a display screen, a touch screen, a speaker, a button, a switch, or any other element capable of providing information to a user or receiving input from a user. In some embodiments, the control circuit 132 is configured to generate a graphical user interface and cause the graphical user interface to be displayed on the user interface 128. The graphical user interface may include various information about the NPIWT provided by the NPIWT system 100, for example relating to the pressure in the sealed space, an amount of instillation fluid to be provided, a schedule of negative pressure and instillation cycles, and/or a size of the wound space 120. The user interface 128 may allow a user to input commands and settings relating to the operation of the therapy unit 108. The control circuit 132 may receive such inputs from the user interface 128 and control the therapy unit 108 in accordance with the inputs.
The instillation pump 130 is configured to cause instillation fluid to be transported from the instillation fluid source 110 to the wound space 120 via second tubing 112. The instillation pump 130 may be controllable by the control circuit 132 to provide a desired amount of the instillation fluid to the wound space 120, provide instillation fluid to the wound space 120 at a desired rate, prevent instillation fluid from flowing to the wound space 120, or otherwise control the flow of instillation fluid to the wound space 120. The instillation pump may include a peristaltic pump or some other type of pump.
The first valve 125 and second valve 126 are controllable between an open position and a closed position. As shown in
The control circuit 132 is configured to control the operation of the therapy unit 108. For example, as described in detail below, the control circuit 132 is configured to control the pneumatic pump 122 to remove air from the sealed space to establish a negative pressure in the sealed space, control the first valve 125 to provide a controlled leak to the sealed space, receive pressure measurements from the first sensor 123, determine a volume of the wound space 120 based on the pressure measurements, and customize a wound therapy based on the volume of the wound space 120. Although the control circuit 132 is described herein as to determine a volume of the wound space 120, the control circuit 132 may additionally, or alternatively, use the pressure measurements to determine a rate of dwell therapy, a frequency of periodic instillation therapy, or a volume of constant stream instillation. Accordingly, although the system is described herein as applying an instillation fluid, any other fluid (e.g., collagen) may be used.
Referring now to
Orifice 404 is shown to include an orifice lumen 204 extending therethrough and defining a second inner diameter 206. The orifice lumen 204 extends through the orifice 404 such that a first end 208 of vacuum tubing 403 is in fluid communication with a second end 210 of vacuum tubing 403 that extends in an opposite direction of the first end 208. The second inner diameter 206 is smaller than the first inner diameter 202 and may be configurable based on factors such as tubing size, therapy unit parameters, wound treatment parameters, etc. In some embodiments, the second inner diameter 206 ranges between a first value of approximately 0.1 mm and a second value of 1.0 mm. In some embodiments, the second inner diameter 206 ranges between a first value of approximately 0.2 mm and a second value of 0.75 mm. In some embodiments, the second inner diameter 206 ranges between a first value of approximately 0.33 mm and a second value of approximately 0.43 mm. In some embodiments, the second inner diameter 206 is approximately 0.38 mm. Orifice 404 is also shown to have a length 212 extending along outer lumen 402. In various arrangements, the size of second inner diameter 206 is related to a size (e.g., volume, cross-section, thickness, length) of filter 138. The size of length 212 may be less than a length of vacuum tubing 403 (not shown). Accordingly, the size of length 212 may be customizable based on factors such as therapy unit parameters, wound size, etc.
Referring now to
Referring now to
Referring now to
Referring now to
At step 702, a sealed space defined by the wound bed 114, the dressing 102, the first tubing 106, and the canister 104 is established. The sealed space includes the wound space 120. In other words, the dressing 102 is applied to the wound bed 114 with the drape 116 sealed over the wound bed 114 and the manifold layer 118 (or other layers included in the dressing 102 in various embodiments) to define the wound space 120. The first tubing 106 is coupled to the drape 116 in fluid communication with the wound space 120 via the connection pad 121. The first tubing 106 is also coupled to the canister 104 in fluid communication with the canister 104 or therapy unit 108. The first tubing 106 also defines a lumen having first inner diameter 202 extend therethrough.
At step 704, orifice 404 having a second inner diameter 206 that is less than the first inner diameter 202 is provided. In some embodiments, the second inner diameter 206 ranges between a first value of approximately 0.1 mm and a second value of 1.0 mm. In some embodiments, the second inner diameter 206 ranges between a first value of approximately 0.2 mm and a second value of 0.75 mm. In some embodiments, the second inner diameter 206 ranges between approximately 0.33 mm and 0.43 mm. In some embodiments, orifice 404 may be provided as a discrete disc component defining the orifice lumen 204 extending therethrough and configured for placement within the lumen of the vacuum tubing 403. Alternatively, the orifice 404 may be provided as a component formed monolithically with the vacuum tubing 403. The orifice 404 may be located at various locations such as between the therapy unit 108 and the canister 104, at an interface of the vacuum tubing 403 and the canister 104, within the therapy unit 108, or at an interface of the therapy unit 108 and the vacuum tubing 403. In some embodiments, orifice 404 may be structured as bellows 300 configured to fluidly and sealably couple the vacuum tubing 403 with the canister 104 or the therapy unit 108.
At step 706, the pneumatic pump 122 is operated to draw a negative pressure in the sealed space. That is, the control circuit 132 provides a control signal to the pneumatic pump 122 that causes the pneumatic pump to remove air from the sealed space. The control circuit 132 may receive pressure measurements from first sensor 123 and cause the pneumatic pump 122 to cease operation when a desired negative pressure is achieved (e.g., −125 mmHg) and/or otherwise control the pneumatic pump 122 based on the pressure measurements to provide a desired negative pressure or pattern of desired negative pressures.
At step 708, the first valve 125 is repeatedly opened and closed (e.g., “cycled”) to allow a controlled rate of airflow therethrough. The control circuit 132 may provide a control signal to the first valve 125 that causes the first valve 125 to repeatedly open and close. For example, in an embodiment where the first valve 125 is a solenoid valve, the control circuit 132 provides a voltage pattern to the first valve 125. That is, the control circuit 132 may repeatedly alternate a voltage differential across between a positive lead and a negative lead between approximately zero volts and a non-zero voltage (e.g., approximately five volts). For example, the voltage pattern may include a step function that repeatedly steps between approximately zero voltage and the non-zero voltage.
At step 710, the pressure in the sealed space is measured as the negative pressure in the sealed space decays towards ambient pressure (i.e., approaches approximately atmospheric pressure). The controlled airflow through the first valve 125 allows air to enter the sealed space and causes the pressure in the sealed space to decay towards ambient pressure. The first sensor 123 may measure the pressure in the sealed space and provide the pressure measurements to the control circuit 132. The control circuit 132 may record (store, save) the pressure measurements. In some embodiments, the control circuit 132 may collect the pressure measurements to form a pressure decay curve.
At step 712, the volume of the wound space 120 is determined based on the pressure measurements. For example, based on the known controlled rate of airflow through the first valve 125 and the measured pressure decay curve, the volume of the sealed space may be determined. The volume of the wound space may then be determined by removing a volume of the canister and tube from the total volume of the sealed space. In some cases, one or more additional valves, sensors, etc. are included to facilitate generation and collection of data for use in wound size determination. Various methods for calculating wound size are described in U.S. Patent Application No. 62/802,034 filed Feb. 6, 2019, incorporated by reference herein in its entirety.
At step 714, the wound size (e.g., the volume of the wound space 120) and/or a message relating thereto is displayed on the user interface 128. For example, the control circuit 132 may cause a graphical user interface that includes the wound size to be displayed on a screen of the user interface 128. As another example, the control circuit 132 may determine one or more warnings, progress reports, or other wound-related message based on the wound size and control the user interface 128 to display the warning, report, or other message. For example, the user interface 128 may display a graphical representation of change in the volume of the wound space over time.
At step 716, a wound therapy is customized based on the volume of the wound space. In some embodiments, the control circuit 132 automatically customizes a wound therapy based on the determined volume of the wound space 120. In other embodiments, a user is facilitated in customizing a wound therapy based on the volume of the wound space 120 based on information displayed on the user interface 128.
In the example shown, the control circuit 132 automatically customizes instillation by automatically determining an amount of instillation fluid to be supplied to the wound space 120 based on the determined volume of the wound space 120. For example, the control circuit 132 may multiple the determined volume of the wound space 120 by a scaling factor to determine the amount of instillation fluid to be supplied to the wound space 120. As another example, the control circuit 132 may determine the amount of instillation to be supplied as equal to the volume of the wound space 120. Various calculations are possible for various applications, wound types, instillation fluid types, patient and/or caregiver preferences, etc.
At step 718, the customized wound therapy is provided. For example, the control circuit 132 may control the instillation pump 130 to provide the determined amount of instillation fluid from the instillation fluid source 110 to the wound space 120. Instillation therapy may thereby be tailored to meet the needs of the healing wound in real time. Various other customized therapies are possible in various embodiments.
Configuration of Exemplary Embodiments
As utilized herein, the terms “approximately,” “about,” “substantially,” and similar terms are intended to have a broad meaning in harmony with the common and accepted usage by those of ordinary skill in the art to which the subject matter of this disclosure pertains. It should be understood by those of skill in the art who review this disclosure that these terms are intended to allow a description of certain features described and claimed without restricting the scope of these features to the precise numerical ranges provided. Accordingly, these terms should be interpreted as indicating that insubstantial or inconsequential modifications or alterations of the subject matter described and claimed are considered to be within the scope of the disclosure as recited in the appended claims.
It should be noted that the term “exemplary” and variations thereof, as used herein to describe various embodiments, are intended to indicate that such embodiments are possible examples, representations, or illustrations of possible embodiments (and such terms are not intended to connote that such embodiments are necessarily extraordinary or superlative examples).
The term “coupled” and variations thereof, as used herein, means the joining of two members directly or indirectly to one another. Such joining may be stationary (e.g., permanent or fixed) or moveable (e.g., removable or releasable). Such joining may be achieved with the two members coupled directly to each other, with the two members coupled to each other using a separate intervening member and any additional intermediate members coupled with one another, or with the two members coupled to each other using an intervening member that is integrally formed as a single unitary body with one of the two members. If “coupled” or variations thereof are modified by an additional term (e.g., directly coupled), the generic definition of “coupled” provided above is modified by the plain language meaning of the additional term (e.g., “directly coupled” means the joining of two members without any separate intervening member), resulting in a narrower definition than the generic definition of “coupled” provided above. Such coupling may be mechanical, electrical, or fluidic.
References herein to the positions of elements (e.g., “top,” “bottom,” “above,” “below”) are merely used to describe the orientation of various elements in the FIGURES. It should be noted that the orientation of various elements may differ according to other exemplary embodiments, and that such variations are intended to be encompassed by the present disclosure. Although the figures show a specific order of method steps, the order of the steps may differ from what is depicted. Also two or more steps can be performed concurrently or with partial concurrence. Such variation will depend on the software and hardware systems chosen and on designer choice. All such variations are within the scope of the disclosure. Likewise, software implementations could be accomplished with standard programming techniques with rule based logic and other logic to accomplish the various connection steps, calculation steps, processing steps, comparison steps, and decision steps.
The construction and arrangement of the systems and methods as shown in the various exemplary embodiments are illustrative only. Although only a few embodiments have been described in detail in this disclosure, many modifications are possible (e.g., variations in sizes, dimensions, structures, shapes and proportions of the various elements, values of parameters, mounting arrangements, use of materials, colors, orientations, etc.). For example, the position of elements can be reversed or otherwise varied and the nature or number of discrete elements or positions can be altered or varied. Accordingly, all such modifications are intended to be included within the scope of the present disclosure. The order or sequence of any process or method steps can be varied or re-sequenced according to alternative embodiments. Other substitutions, modifications, changes, and omissions can be made in the design, operating conditions and arrangement of the exemplary embodiments without departing from the scope of the present disclosure.
This application is a U.S. National Stage entry of International Patent Application No. PCT/M2021/050619, filed Jan. 27, 2021, which claims the benefit of priority to U.S. Provisional Application No. 62/967,133, filed on Jan. 29, 2020, which is incorporated herein by reference in its entirety.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/IB2021/050619 | 1/27/2021 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 62967133 | Jan 2020 | US |
